NowoTrade

EWTX

EWTX Edgewise Therapeutics, Inc.

Stock · NasdaqGS · United States · Healthcare · US28036F1057

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Edgewise Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 45.04 USD +15.87%
52-week range 16.70 – 48.51
Dividend yield—
Market cap4.9B
NowoTrade score 26 Grade C

Price history

Daily prices in USD.

Updated 06 Nov 2026 21:02. Information, not advice.

Results

Next results 25 Feb 2027 in 110 days · 16:00 · estimate -0.47
Last results 9.65 vs 2.51 estimated 04 Nov 2026 · Beat +284.0%
Beat the estimate 6 of 12 4 missed · 2 in line
Average surprise +25.4% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

22 Feb 2024: estimate -0.43 22 Feb 2024: reported -0.47 02/24 09 May 2024: estimate -0.41 09 May 2024: reported -0.33 05/24 08 Aug 2024: estimate -0.34 08 Aug 2024: reported -0.34 08/24 07 Nov 2024: estimate -0.37 07 Nov 2024: reported -0.36 11/24 03 Mar 2025: estimate -0.42 03 Mar 2025: reported -0.42 03/25 08 May 2025: estimate -0.42 08 May 2025: reported -0.43 05/25 07 Aug 2025: estimate -0.42 07 Aug 2025: reported -0.34 08/25 06 Nov 2025: estimate -0.40 06 Nov 2025: reported -0.39 11/25 26 Feb 2026: estimate -0.44 26 Feb 2026: reported -0.47 02/26 07 May 2026: estimate -0.48 07 May 2026: reported -0.46 05/26 06 Aug 2026: estimate -0.47 06 Aug 2026: reported -0.53 08/26 04 Nov 2026: estimate 2.51 04 Nov 2026: reported 9.65 11/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
25 Feb 2027 16:00 -0.47 — — Upcoming
04 Nov 2026 16:00 2.51 9.65 +284.0% Beat
06 Aug 2026 08:00 -0.47 -0.53 -12.2% Miss
07 May 2026 08:00 -0.48 -0.46 +5.2% Beat
26 Feb 2026 08:00 -0.44 -0.47 -6.3% Miss
06 Nov 2025 08:00 -0.40 -0.39 +2.8% Beat
07 Aug 2025 08:00 -0.42 -0.34 +18.3% Beat
08 May 2025 08:00 -0.42 -0.43 -2.1% Miss
03 Mar 2025 08:00 -0.42 -0.42 +0.5% In line
07 Nov 2024 08:00 -0.37 -0.36 +3.3% Beat
08 Aug 2024 08:00 -0.34 -0.34 +0.6% In line
09 May 2024 08:00 -0.41 -0.33 +19.1% Beat
22 Feb 2024 08:00 -0.43 -0.47 -8.4% Miss
09 Nov 2023 08:00 -0.40 -0.41 -3.0% Miss
10 Aug 2023 08:00 -0.40 -0.34 +14.1% Beat
11 May 2023 08:00 -0.35 -0.36 -3.7% Miss
23 Feb 2023 08:00 -0.33 -0.31 +6.9% Beat
03 Nov 2022 08:00 -0.36 -0.34 +4.2% Beat
04 Aug 2022 08:00 -0.32 -0.32 +1.5% Beat
11 May 2022 08:00 -0.28 -0.30 -6.2% Miss
24 Feb 2022 08:00 -0.26 -0.26 -0.7% In line
10 Nov 2021 08:00 -0.24 -0.26 -6.7% Miss
09 Aug 2021 09:00 -0.17 -0.21 -22.6% Miss
13 May 2021 16:00 -0.15 -0.14 +7.7% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 0 — -167.8M — -1.63 -288.1% -144.1M
2024 0 — -133.8M — -0.42 +73.2% -110.3M
2023 0 — -100.2M — -1.57 -406.5% -97.7M
2022 0 — -67.6M — -0.31 — -58.2M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
26 Jul 2023 6.99 7.42 6.99 7.23 +3.43% 136,400
25 Jul 2023 7.33 7.36 6.95 6.99 -5.16% 570,500
24 Jul 2023 7.67 7.69 7.20 7.37 -4.16% 160,000
21 Jul 2023 7.37 7.92 7.37 7.69 +4.77% 292,500
20 Jul 2023 7.15 7.51 7.00 7.34 +2.66% 864,200
19 Jul 2023 7.13 7.32 7.02 7.15 +0.28% 220,800
18 Jul 2023 7.27 7.45 7.08 7.13 -1.93% 95,800
17 Jul 2023 7.24 7.53 7.20 7.27 +0.69% 139,100
14 Jul 2023 7.47 7.52 7.17 7.22 -3.35% 118,400
13 Jul 2023 7.49 7.83 7.43 7.47 -0.13% 211,400
12 Jul 2023 7.22 7.53 7.08 7.48 +6.25% 386,300
11 Jul 2023 7.15 7.35 7.00 7.04 -2.36% 333,900
10 Jul 2023 7.29 7.77 7.11 7.21 -1.10% 315,800
07 Jul 2023 7.46 7.55 7.18 7.29 -1.88% 85,400
06 Jul 2023 7.61 7.67 7.31 7.43 -3.00% 248,900
05 Jul 2023 7.50 7.78 7.40 7.66 +1.59% 249,300
03 Jul 2023 7.61 7.86 7.47 7.54 -2.71% 89,000
30 Jun 2023 7.98 7.98 7.45 7.75 +2.92% 399,700
29 Jun 2023 7.52 7.62 7.44 7.53 -0.40% 226,500
28 Jun 2023 7.95 8.05 7.47 7.56 +0.67% 196,000
27 Jun 2023 6.88 7.66 6.76 7.51 +9.48% 375,600
26 Jun 2023 7.54 7.59 6.83 6.86 -9.74% 253,200
23 Jun 2023 7.78 7.83 7.40 7.60 -2.94% 1,061,500
22 Jun 2023 7.90 8.15 7.77 7.83 -1.76% 209,000
21 Jun 2023 8.17 8.27 7.90 7.97 -2.69% 200,900

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

Key data

Previous close
38.87 USD
Market cap
4.9B
Exchange
NasdaqGS
Country
United States
Sector
Healthcare
Industry
Biotechnology
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 8.8 / 25 No figures for this part: it counts as a cautious 35%. —
Quality Return on equity, net margin and how stable the margins are. 0.0 / 25
  • ROE of -38%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 3.8 / 20
  • Free cash flow yield of -1.9%
Valuation Free cash flow yield and the P/E against its sector. 7.5 / 15
  • P/E 5.4 against 31.1 for its sector
Analysts How far the analysts' average target is from today's price. 10.0 / 10
  • Analysts' target is +20% from the price
  • Score capped at 60: free cash flow was negative in two of the last three years
  • The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 70% of the figures (grade C). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 5.37× Good 31.09×
P/E (forward) -24.1× Weak 14.98×
Price / book 9.16× Weak 4×
EV / EBITDA -16.69× Weak 13.22×
Free cash flow yield -1.9% Weak 2.6%
Quality
FigureValueReading Sector median
Gross margin 0% Weak 59.2%
Operating margin 0% Weak 7.8%
Net margin 0% Weak 3.2%
Return on equity -38% Weak 5.8%
Return on assets -25% Weak 3.6%
Financial health
FigureValueReading Sector median
Debt / equity 0.01× Good 0.46×
Current ratio 16.24× Good 2.35×

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow EWTX and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in